OnCo
Start hereTagsrare-cancers

rare-cancers

All tags →

No description yet: the sentence for this tag has not been written. 5 records carry it: 5 people.

5 records
Alice P. Chen
Medical oncologist, Division of Cancer Treatment and Diagnosis, National Cancer Institute · National Cancer Institute (NIH)
NCI oncologist who led the trial that showed atezolizumab produces lasting responses in alveolar soft part sarcoma, the first approved treatment for this rare cancer.
Andrew J. Wagner
Sarcoma medical oncologist, Dana-Farber Cancer Institute · Dana-Farber Brigham Cancer Center
Boston sarcoma doctor who first showed that mTOR inhibitors shrink perivascular epithelioid cell tumours and then led AMPECT, the trial that made nab-sirolimus the first approved treatment for these rare cancers.
Richard D. Carvajal
Deputy Physician-in-Chief and Director of Medical Oncology, Northwell Health Cancer Institute · Northwell Health Cancer Institute
Melanoma oncologist who led the tebentafusp programme in the United States and defined targeted therapy for rare melanoma subtypes.
Scott R. Plotkin
Neuro-oncologist and Director of the Family Center for Neurofibromatosis, Massachusetts General Hospital · Massachusetts General Hospital Cancer Center
Boston neuro-oncologist who showed that bevacizumab can shrink vestibular schwannomas and restore hearing in people with neurofibromatosis type 2.
Silvia Stacchiotti
Medical Oncologist, Adult Mesenchymal Tumour and Rare Cancer Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan · Fondazione IRCCS Istituto Nazionale dei Tumori
Italian oncologist who leads histology-specific trials in ultra-rare sarcomas and the Connective Tissue Oncology Society.

This tag as JSON · API